Sana Biotechnology Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Tessa Romero. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Taylor Hanley and Adhiraj Chauhan from the team.
Our next presenting company is Sana, and speaking on behalf of the company, we have CEO, Steve Harr. Before I turn it over to Steve, I just wanted to highlight that for Q&A after the formal presentation, there is an Ask a Question button in the portal, which should allow you to submit your questions, and I'm happy to ask the question on your behalf. We are also taking live questions here in the audience.
So just wave your hand and we'll get your question in.
So with that, I'm going to hand it over to Steve.
Well, thank you, Tessa, and thank you, JPMorgan. Thank you everybody here in the audience as well as online for joining us. We're thrilled to have a chance to tell
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |